ScienceMachine raises 2.9m to accelerate biotech with AI
EU-Startups - 09-Jul-2025AI startup ScienceMachine speeds up drug discovery by automating complex biotech data analysis
Investments News
Chugai, Gero ink $250m deal to target ageing
FierceBiotech - 07-Jul-2025Gero’s AI will uncover ageing targets; Chugai will develop antibody drugs to treat related diseases
China’s brain chips break new ground
Nature - 04-Jul-2025BCIs in China help paralysed users control devices, play games, and speak Mandarin in real time
DNA reborn: engineering life from scratch
BBC - 26-Jun-2025UK project aims to build human DNA from scratch, raising hopes for cures—and ethical concerns
Calico taps Mabwell’s anti-ageing antibody in $596m licensing deal
FierceBiotech - 26-Jun-2025Alphabet's Calico licenses IL-11 drug to target age-related diseases beyond China
Outsee raises 1.8m for AI genomics in drug discovery
Longevity Technology - 25-Jun-2025Nomaly uses AI to decode disease from genomes, enabling precision medicine with small datasets
Infinity Bio raises $8m to decode the antibody reactome
Longevity Technology - 24-Jun-2025Tech screens 1,000s of antibodies per assay; links chronic inflammation to faster ageing
Robot surgeons for eyes: ForSight aims to revolutionize cataract surgery
Forbes - 24-Jun-2025ForSight’s $125M boost powers eye-surgery robot tested in 300 pig-eye trials, human ops next
Cidara’s new flu drug shows strong protection in adults
BioPharma Dive - 23-Jun-2025It may be a potential one-time seasonal alternative to vaccines without serious side effects
Parallel Bio raises $21m to replace animal testing with human immune organoids
Longevity Technology - 17-Jun-2025New platform aims to cut drug discovery by $2B and 9 years using lab-grown human immune models
Juvena strikes $650m deal with lilly to tackle obesity
Longevity Technology - 11-Jun-2025AI-driven protein therapies aim to boost muscle health and metabolism alongside weight loss
Splicebio raises $135m to advance gene therapy for eye disease
FierceBiotech - 11-Jun-2025SB-007 enters phase 1/2 trials to restore vision in Stargardt disease using novel splicing tech
University spin-out Astratus unveils breakthrough in antibiotic testing
University of Reading - 10-Jun-2025New tech delivers same-day results to improve prescriptions and curb rising antimicrobial resistance
AI-driven leap: Juvenescence expands R&D capabilities with Ro5 acquisition
Longevity Technology - 05-Jun-2025Ro5’s AI platform boosts Juvenescence’s age-related drug pipeline and fuels UAE healthtech push
AI-powered biotech Vivodyne aims to end animal testing with $40m funding boost
Longevity Technology - 30-May-2025Biotech firm uses AI and robotics to test drugs on real human tissues, not animals
Magnitude Biosciences secures funding to boost AI-powered drug discovery
BusinessLive - 29-May-2025Biotech firm to create skilled jobs as it scales innovative platform for healthier ageing therapies
Neuralink raised $600 million, reaching a $9 billion valuation
Longevity Technology - 28-May-2025The company is still in early stages but attracting strong investor interest
Maxwell’s AI platform drives revenue growth through health innovation
Live Forever Club - 27-May-2025India partnerships and FDA progress boost future income
Boundless bio cuts staff and rethinks strategy after lead drug fails in early trials
FierceBiotech - 27-May-2025Biotech pivots to drug combo after monotherapy safety and efficacy setbacks
Starfish neuroscience unveils plans for tiny, wireless brain chip
The Verge - 24-May-2025Valve CEO’s BCI firm builds battery-free chip to interact with multiple brain regions
Altos Labs expands longevity portfolio with Dorian Therapeutics acquisition
Longevity Technology - 23-May-2025Dorian’s anti-senescence tech adds firepower to Altos Labs’ rejuvenation strategy
Tomorrow.Bio raises 5m to bring cryonics and life-after-death hopes to the U.S.
EU-Startups - 22-May-2025Berlin startup freezes bodies, hoping for future revival
UK biotech Juvenescence secures over $150m to develop therapies
Endpoints News - 21-May-2025Juvenescence expands pipeline and UAE presence with new funding to tackle age-related diseases
23andMe’s fall from fame ends in Regeneron takeover
BBC - 19-May-2025Regeneron buys 23andMe for $256M, pledges to protect user data and boost drug discovery
AI startup Somite raises $47m to revolutionize stem cell therapy
Longevity Technology - 16-May-2025Somite AI uses DeltaStem to speed up and scale stem cell engineering
Display all news
